Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series – Gastrointestinal Cancer Update – Podcast

Episodes

The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review
6 nov.· Gastrointestinal Cancer Update
Dr Tanios Bekaii-Saab from Mayo Clinic in Phoenix, Arizona, and Dr Philip A Philip from the Henry Ford Cancer Institute in Detroit, Michigan, discuss recent research presentations on the treatment of gastrointestinal cancers.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors
18 oct.· Gastrointestinal Cancer Update
Dr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for desmoid tumors and review novel options for targeted therapy.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Episodes manquant?

Cliquez ici pour raffraichir la page manuellement.
Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers
20 sept.· Gastrointestinal Cancer Update
Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
19 sept.· Gastrointestinal Cancer Update
Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
13 sept.· Gastrointestinal Cancer Update
Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma
10 sept.· Gastrointestinal Cancer Update
Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
16 juil.· Gastrointestinal Cancer Update
Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
3 mai· Gastrointestinal Cancer Update
Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
16 avril· Gastrointestinal Cancer Update
Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
8 avril· Gastrointestinal Cancer Update
Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
21 mars· Gastrointestinal Cancer Update
Dr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellular carcinoma and biliary tract cancers.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
7 mars· Gastrointestinal Cancer Update
Dr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
23 févr.· Gastrointestinal Cancer Update
Dr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers
14 déc. 2023· Gastrointestinal Cancer Update
Dr Lipika Goyal from The Stanford Cancer Center and Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston discuss targeted and immunotherapeutic approaches for biliary tract cancers.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series
6 déc. 2023· Gastrointestinal Cancer Update
Dr Samuel J Klempner from Massachusetts General Hospital in Boston discusses optimizing the management of gastroesophageal cancers.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series
15 nov. 2023· Gastrointestinal Cancer Update
Prof Eric Van Cutsem from the University Hospitals Leuven in Leuven, Belgium, discusses optimizing the management of gastroesophageal cancers.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series
23 oct. 2023· Gastrointestinal Cancer Update
Featuring a discussion on current and emerging strategies for the treatment of upper GI cancers with Dr Peter C Enzinger, moderated by Dr Neil Love.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Oncology Today with Dr Neil Love: Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian
13 oct. 2023· Gastrointestinal Cancer Update
Dr Michael Pishvaian from the Johns Hopkins University School of Medicine in Washington, DC, discusses recent updates on available and novel treatment strategies for pancreatic cancer.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
$Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer$

Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer
6 oct. 2023· Gastrointestinal Cancer Update
Dr Kristen K Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and Dr J Randolph Hecht from UCLA’s David Geffen School of Medicine in Santa Monica, California, discuss the current management and actual cases of relapsed/refractory metastatic colorectal cancer.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Inside the Issue: Optimizing the Management of Metastatic Pancreatic Cancer
18 sept. 2023· Gastrointestinal Cancer Update
Dr Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer.
- Écouter Écoute encore Continuer Écoutez...
- Écoutez plus tard Écoutez plus tard
Montre plus

Episodes

The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review

Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors

Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers

Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors

Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma

RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer

Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer

Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers

Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers

Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series

Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series

Oncology Today with Dr Neil Love: Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian

Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer

Inside the Issue: Optimizing the Management of Metastatic Pancreatic Cancer